Over 11,000 Bottles of Blood Pressure Medication Recalled Nationwide: FDA Notice

The notice said chlorthalidone tablets are under recall due to ‘failed dissolution specifications.’

The U.S. Food and Drug Administration in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

A drug manufacturer said that more than 11,000 bottles of prescription blood pressure medication are under recalls, according to a notice published this week on the Food and Drug Administration’s (FDA) website.

The notice said that chlorthalidone tablets, USP, in 25-milligram doses, are under recall for “failed dissolution specifications.” It added that 11,460 bottles are under recall, and the products have an April 2027 expiration date.